EdgarLookup

Cardiff Lexington Corp — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Cardiff Lexington Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-47.7%
Profit Margin
Net income ÷ revenue
-18.9%
Return on Assets
Net income ÷ assets
-10.53x
Debt-to-Equity
Total liabilities ÷ equity
+39.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.54M Mar 10, 2026
FY2025 Dec 31, 2024 $8.27M Mar 10, 2026
FY2024 Dec 31, 2023 $11.85M Aug 19, 2025
FY2023 Dec 31, 2022 $10.69M Aug 8, 2024
FY2022 Dec 31, 2021 $9.88M Jun 6, 2023
FY2021 Dec 31, 2020 $3.45M Oct 26, 2022
FY2020 Dec 31, 2019 $3.71M Feb 18, 2022
FY2019 Dec 31, 2018 $2.23M Apr 16, 2020
FY2018 Dec 31, 2017 $1.63M Apr 22, 2019
FY2017 Dec 31, 2016 $1.15M Jul 2, 2018

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2019 Dec 31, 2019 $4.54M Apr 16, 2020
FY2019 Dec 31, 2018 $2.23M Apr 16, 2020

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.21M Mar 10, 2026
FY2025 Dec 31, 2024 $4.43M Mar 10, 2026
FY2024 Dec 31, 2023 $8.29M Aug 19, 2025
FY2023 Dec 31, 2022 $6.63M Aug 8, 2024
FY2022 Dec 31, 2021 $6.11M Jun 6, 2023
FY2021 Dec 31, 2020 $1.78M Oct 26, 2022
FY2020 Dec 31, 2019 $2.04M Feb 18, 2022
FY2019 Dec 31, 2018 $755.8K Apr 16, 2020
FY2018 Dec 31, 2017 $193.9K Apr 22, 2019
FY2017 Dec 31, 2016 $353.2K Jul 2, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($5.51M) Mar 10, 2026
FY2025 Dec 31, 2024 ($3.30M) Mar 10, 2026
FY2024 Dec 31, 2023 $3.03M Aug 19, 2025
FY2023 Dec 31, 2022 ($5.43M) Aug 8, 2024
FY2022 Dec 31, 2021 $666.3K Jun 6, 2023
FY2021 Dec 31, 2020 ($2.84M) Oct 26, 2022
FY2020 Dec 31, 2019 ($7.18M) Feb 18, 2022
FY2019 Dec 31, 2018 ($6.27M) Apr 16, 2020
FY2018 Dec 31, 2017 ($3.65M) Apr 22, 2019
FY2017 Dec 31, 2016 ($2.25M) Jul 2, 2018

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.10M Mar 10, 2026
FY2025 Dec 31, 2024 ($193.5K) Mar 10, 2026
FY2024 Dec 31, 2023 $5.20M Aug 19, 2025
FY2023 Dec 31, 2022 $3.91M Aug 8, 2024
FY2022 Dec 31, 2021 $1.66M Jun 6, 2023
FY2021 Dec 31, 2020 ($1.80M) Oct 26, 2022
FY2020 Dec 31, 2019 ($1.27M) Feb 18, 2022
FY2019 Dec 31, 2018 ($2.02M) Apr 16, 2020
FY2018 Dec 31, 2017 ($2.99M) Apr 22, 2019
FY2017 Dec 31, 2016 ($2.16M) Jul 2, 2018

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.33M Mar 10, 2026
FY2025 Dec 31, 2024 $4.06M Mar 10, 2026
FY2024 Dec 31, 2023 $3.08M Aug 19, 2025
FY2023 Dec 31, 2022 $2.70M Aug 8, 2024
FY2022 Dec 31, 2021 $4.43M Jun 6, 2023
FY2021 Dec 31, 2020 $3.59M Oct 26, 2022
FY2020 Dec 31, 2019 $3.31M Feb 18, 2022
FY2019 Dec 31, 2018 $2.76M Apr 16, 2020
FY2018 Dec 31, 2017 $2.06M Apr 22, 2019
FY2017 Dec 31, 2016 $2.51M Jul 2, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 ($1.72M) Aug 8, 2024
FY2023 Dec 31, 2022 ($1.15M) Aug 8, 2024
FY2019 Dec 31, 2019 ($1.05M) Apr 16, 2020
FY2019 Dec 31, 2018 ($1.10M) Apr 16, 2020
FY2018 Dec 31, 2017 ($614.9K) Apr 22, 2019
FY2017 Dec 31, 2016 ($198.1K) Jul 2, 2018
FY2012 Dec 31, 2012 ($255.8K) Jan 21, 2014
FY2012 Dec 31, 2011 ($300.7K) Jan 21, 2014
FY2011 Dec 31, 2010 ($196.1K) Mar 30, 2012

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $0 Jun 6, 2023
FY2022 Dec 31, 2021 $3.4K Jun 6, 2023
FY2021 Dec 31, 2020 $0 Oct 26, 2022
FY2018 Dec 31, 2018 $852.0K Apr 22, 2019
FY2018 Dec 31, 2017 $0 Apr 22, 2019
FY2017 Dec 31, 2016 $18.7K Jul 2, 2018
FY2016 Dec 31, 2015 $109.5K Apr 17, 2017
FY2015 Dec 31, 2014 $0 Oct 31, 2016
FY2012 Dec 31, 2012 $0 Jan 21, 2014
FY2012 Dec 31, 2011 $43.0K Jan 21, 2014

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $29.09M Mar 10, 2026
FY2025 Dec 31, 2024 $23.93M Mar 10, 2026
FY2024 Dec 31, 2023 $20.75M Aug 19, 2025
FY2023 Dec 31, 2022 $13.34M Aug 8, 2024
FY2022 Dec 31, 2021 $15.30M Jun 6, 2023
FY2021 Dec 31, 2020 $4.93M Oct 26, 2022
FY2020 Dec 31, 2019 $4.92M Feb 18, 2022
FY2019 Dec 31, 2018 $3.33M Apr 16, 2020
FY2018 Dec 31, 2017 $1.32M Apr 22, 2019
FY2017 Dec 31, 2016 $2.47M Jul 2, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $26.01M Mar 10, 2026
FY2025 Dec 31, 2024 $16.32M Mar 10, 2026
FY2024 Dec 31, 2023 $14.12M Aug 19, 2025
FY2023 Dec 31, 2022 $10.19M Aug 8, 2024
FY2022 Dec 31, 2021 $11.44M Jun 6, 2023
FY2021 Dec 31, 2020 $13.80M Oct 26, 2022
FY2020 Dec 31, 2019 $11.64M Feb 18, 2022
FY2019 Dec 31, 2018 $8.18M Apr 16, 2020
FY2018 Dec 31, 2017 $4.75M Apr 22, 2019
FY2017 Dec 31, 2016 $4.07M Jul 2, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($2.47M) Mar 10, 2026
FY2025 Dec 31, 2024 $2.69M Mar 10, 2026
FY2025 Dec 31, 2023 $731.4K Mar 10, 2026
FY2024 Dec 31, 2022 ($1.74M) Aug 19, 2025
FY2023 Dec 31, 2021 $486.8K Aug 8, 2024
FY2022 Dec 31, 2020 ($8.87M) Jun 6, 2023
FY2021 Dec 31, 2019 ($6.73M) Oct 26, 2022
FY2020 Dec 31, 2018 ($4.85M) Feb 18, 2022
FY2019 Dec 31, 2017 ($3.43M) Apr 16, 2020
FY2018 Dec 31, 2016 ($1.60M) Apr 22, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.67M Mar 10, 2026
FY2025 Dec 31, 2024 $5.67M Mar 10, 2026
FY2024 Dec 31, 2023 $5.67M Aug 19, 2025
FY2023 Dec 31, 2022 $5.67M Aug 8, 2024
FY2022 Dec 31, 2021 $7.76M Jun 6, 2023
FY2022 Dec 31, 2020 $7.76M Jun 6, 2023
FY2021 Dec 31, 2019 $3.50M Oct 26, 2022
FY2019 Dec 31, 2018 $2.09M Apr 16, 2020
FY2018 Dec 31, 2017 $0 Apr 22, 2019
FY2017 Dec 31, 2016 $932.5K Jul 2, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($79.49M) Mar 10, 2026
FY2025 Dec 31, 2024 ($72.95M) Mar 10, 2026
FY2024 Dec 31, 2023 ($68.68M) Aug 19, 2025
FY2023 Dec 31, 2022 ($70.93M) Aug 8, 2024
FY2022 Dec 31, 2021 ($65.12M) Jun 6, 2023
FY2021 Dec 31, 2020 ($65.58M) Oct 26, 2022
FY2020 Dec 31, 2019 ($62.56M) Feb 18, 2022
FY2019 Dec 31, 2018 ($55.38M) Apr 16, 2020
FY2018 Dec 31, 2017 ($49.11M) Apr 22, 2019
FY2017 Dec 31, 2016 ($45.46M) Jul 2, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2020 Dec 31, 2020 $279.3K Feb 18, 2022
FY2020 Dec 31, 2019 $100.8K Feb 18, 2022
FY2020 Dec 31, 2018 $158.7K Feb 18, 2022
FY2019 Dec 31, 2017 $207.9K Apr 16, 2020
FY2018 Dec 31, 2016 $62.9K Apr 22, 2019
FY2017 Dec 31, 2015 $71.6K Jul 2, 2018
FY2016 Dec 31, 2014 $46.3K Apr 17, 2017
FY2015 Dec 31, 2013 $4.7K Oct 31, 2016
FY2014 Dec 31, 2012 $1.9K Jul 28, 2016
FY2012 Dec 31, 2011 $8.9K Jan 21, 2014

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $18.56M Mar 10, 2026
FY2024 Dec 31, 2024 $9.21M Aug 19, 2025
FY2023 Dec 31, 2023 $2.28M Aug 8, 2024
FY2022 Dec 31, 2022 $155.6K Jun 6, 2023
FY2021 Dec 31, 2021 $600.9K Oct 26, 2022
FY2012 Dec 31, 2012 $824.2K Jan 21, 2014
FY2012 Dec 31, 2011 $759.2K Jan 21, 2014
FY2011 Dec 31, 2010 $50.0K Mar 30, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2021 0 Jun 6, 2023
FY2016 Dec 31, 2016 0 Apr 17, 2017
FY2016 Dec 31, 2015 0 Apr 17, 2017
FY2015 Dec 31, 2014 (11) Oct 31, 2016
FY2014 Dec 31, 2013 (582) Jul 28, 2016
FY2012 Dec 31, 2012 0 Jan 21, 2014
FY2012 Dec 31, 2011 0 Jan 21, 2014

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2021 0 Jun 6, 2023
FY2015 Dec 31, 2015 0 Oct 31, 2016
FY2015 Dec 31, 2014 (11) Oct 31, 2016
FY2014 Dec 31, 2013 (582) Jul 28, 2016
FY2012 Dec 31, 2012 0 Jan 21, 2014
FY2012 Dec 31, 2011 0 Jan 21, 2014

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 13.70M Mar 10, 2026
FY2025 Dec 31, 2024 5.10M Mar 10, 2026
FY2024 Dec 31, 2023 25,121 Aug 19, 2025
FY2023 Dec 31, 2022 10,997 Aug 8, 2024
FY2022 Dec 31, 2021 166.13M Jun 6, 2023
FY2021 Dec 31, 2020 5.27M Oct 26, 2022
FY2020 Dec 31, 2019 67,742 Feb 18, 2022
FY2019 Dec 31, 2018 602,826 Apr 16, 2020
FY2018 Dec 31, 2017 44,808 Apr 22, 2019
FY2017 Dec 31, 2016 25.22M Jul 2, 2018